Publications by authors named "D Addiss"
Article Synopsis
- * The study involved 390 participants, including those with and without trachomatous trichiasis, and focused on the relevance of stigma-related issues like shame and social avoidance within the cultural context.
- * Both stigma scales demonstrated acceptable internal consistency and cultural validity, with the 5-QSI-AP and 5-QSI-CS showing promising results for assessing stigma, indicating they can help monitor stigma in afflicted populations.
Article Synopsis
- Strongyloidiasis is a widespread parasitic infection affecting 300-600 million people, particularly in tropical regions, and poses serious health risks, especially during immunosuppression, with high fatality rates.
- There have been no significant global health initiatives targeting this disease until recently, when the WHO included it in their roadmap for controlling neglected tropical diseases, highlighting its importance.
- The new WHO guidelines recommend mass drug administration of ivermectin in areas with a prevalence of over 5%, aiming for effective public health strategies to combat strongyloidiasis.
Support groups can create environments that are conducive to healing and well-being, particularly for persons with stigmatizing chronic diseases. In 1998, the support group concept was adapted in Haiti for persons with disabling lymphedema caused by lymphatic filariasis (LF). The project was developed with the expectation that the support group model conceived in the developed world be interpreted and modified by persons affected with lymphedema in the Haitian setting.
View Article and Find Full Text PDFEthical analysis should encompass upstream decisions and their downstream consequences.
View Article and Find Full Text PDFVolunteer community drug distributors (CDDs) have been vital to progress made in the elimination of onchocerciasis and lymphatic filariasis; two neglected tropical diseases amenable to preventive chemotherapy (PC-NTDs). However, formative work in Côte d'Ivoire and Uganda revealed that CDDs can encounter considerable challenges during mass drug administration (MDA). CDDs must be resilient to overcome these challenges, yet little is known about their resilience.
View Article and Find Full Text PDF